SANKAR NAVANEETHAN to Disease Progression
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Disease Progression.
Connection Strength
0.967
-
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 04 29; 4:CD006257.
Score: 0.103
-
Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365.
Score: 0.097
-
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
Score: 0.080
-
Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 05; 71(5):657-665.
Score: 0.066
-
Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
Score: 0.065
-
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63.
Score: 0.056
-
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
Score: 0.048
-
Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007004.
Score: 0.037
-
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51.
Score: 0.036
-
Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009 Nov-Dec; 5(6):662-5.
Score: 0.036
-
Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006 Feb; 99(2):188-9.
Score: 0.029
-
Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2024 05; 83(5):624-635.
Score: 0.025
-
Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 08; 82(2):225-236.
Score: 0.024
-
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort?Study. Nephrol Dial Transplant. 2021 08 27; 36(9):1685-1693.
Score: 0.021
-
Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study. Am J Kidney Dis. 2021 08; 78(2):259-267.
Score: 0.021
-
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 10 27; 10:CD007004.
Score: 0.020
-
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 01; 77(1):56-73.e1.
Score: 0.020
-
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2021 02; 77(2):235-244.
Score: 0.020
-
Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018 09; 72(3):390-399.
Score: 0.017
-
Predicting timing of clinical outcomes in patients?with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018 06; 93(6):1442-1451.
Score: 0.017
-
Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
Score: 0.016
-
Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016 07; 30(5):944-50.
Score: 0.015
-
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12; 315(2):164-74.
Score: 0.014
-
Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83.
Score: 0.014
-
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol. 2014 Dec 05; 9(12):2095-103.
Score: 0.013
-
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014 May 31; (5):CD007784.
Score: 0.013
-
Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014 Apr 29; (4):CD007004.
Score: 0.013
-
Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
Score: 0.013
-
Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Mar; 61(3):404-12.
Score: 0.012
-
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257.
Score: 0.008